optimal sequencing of adcs in endocrine refractory hr /her2- metastatic breast cancer
Published 4 months ago • 29 plays • Length 29:00Download video MP4
Download video MP3
Similar videos
-
29:00
optimal sequencing of adcs in endocrine refractory hr /her2- metastatic breast cancer
-
1:09
where are we in sequencing adcs in hr breast cancer?
-
4:11
targeted sequencing in endocrine refractory breast cancer
-
1:13
dr. esteva on next-generation sequencing in metastatic breast cancer
-
1:37
how can we best sequence adcs in breast cancer?
-
5:00
hematologic adverse events with adcs in breast cancer: optimal management strategies
-
10:23
sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment o...
-
3:01
resistance to adcs in breast cancer and novel combination strategies
-
0:32
quantitative confluency analysis: antibody drug conjugate (adcs) killing mouse breast cancer cells
-
1:33:22
transforming metastatic breast cancer management: harnessing the power of antibody-drug conjugate...
-
27:03
antibody drug conjugates: the end of chemotherapy | 2023 west oncology conference
-
1:02
combination therapies incorporating adcs in breast cancer
-
2:02
dr. soliman the utility of adcs in breast cancer
-
2:06
antibody-drug conjugates for her2-low disease: 2023 ku breast cancer year in review
-
6:42
sequencing in hormone-driven metastatic breast cancer
-
1:52
highlights from esmo breast cancer 2022
-
3:36
her2 breast cancer: evolution of antibody-drug conjugates
-
1:33
antibody-drug conjugates (adcs) in nsclc
-
0:45
do clinical and pathological factors preduct extended endocrine benefit